EnPlusOne Biosciences Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $21.8M

  • Investors
  • 5

EnPlusOne Biosciences General Information

Description

Developer of a synthesis platform intended to revolutionize the diverse array of nucleotide modifications. The company's platform offers enzymatic-based RNA synthesis to address systemic issues inherent to existing chemical synthesis methods and the expansion of RNA therapeutics has uncovered key issues including scaled production and access to innovative therapeutic modifications, enabling the manufacturing process to deliver therapeutic RNA at a commercial scale sustainably.

Contact Information

Website
enplusone.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 313 Pleasant Street
  • Suite 4W
  • Watertown, MA 02472
  • United States
+1 (617)
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 313 Pleasant Street
  • Suite 4W
  • Watertown, MA 02472
  • United States
+1 (617)

EnPlusOne Biosciences Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EnPlusOne Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 19-Feb-2025 $21.8M Completed Generating Revenue
1. University Spin-Out 13-Jun-2022 Completed Startup
To view EnPlusOne Biosciences’s complete valuation and funding history, request access »

EnPlusOne Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a synthesis platform intended to revolutionize the diverse array of nucleotide modifications. The company's
Biotechnology
Watertown, MA

Somerville, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EnPlusOne Biosciences Competitors (1)

One of EnPlusOne Biosciences’s competitors is Genetix Biotherapeutics, a Private Equity-Backed company based in Somerville, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
You’re viewing 1 of 1 competitors. Get the full list »

EnPlusOne Biosciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Breakout Ventures Venture Capital Minority
Coatue Management PE/Buyout Minority
Northpond Ventures Venture Capital Minority
Harvard University University
Wyss Institute at Harvard University University
To view EnPlusOne Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial

EnPlusOne Biosciences FAQs

  • When was EnPlusOne Biosciences founded?

    EnPlusOne Biosciences was founded in 2022.

  • Where is EnPlusOne Biosciences headquartered?

    EnPlusOne Biosciences is headquartered in Watertown, MA.

  • What industry is EnPlusOne Biosciences in?

    EnPlusOne Biosciences’s primary industry is Biotechnology.

  • Is EnPlusOne Biosciences a private or public company?

    EnPlusOne Biosciences is a Private company.

  • What is the current valuation of EnPlusOne Biosciences?

    The current valuation of EnPlusOne Biosciences is .

  • What is EnPlusOne Biosciences’s current revenue?

    The current revenue for EnPlusOne Biosciences is .

  • How much funding has EnPlusOne Biosciences raised over time?

    EnPlusOne Biosciences has raised $21.8M.

  • Who are EnPlusOne Biosciences’s investors?

    Breakout Ventures, Coatue Management, Northpond Ventures, Harvard University, and Wyss Institute at Harvard University have invested in EnPlusOne Biosciences.

  • Who are EnPlusOne Biosciences’s competitors?

    Genetix Biotherapeutics is a competitor of EnPlusOne Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process